MYCN-induced molecular clock disruption and metabolic rewiring drive neuroblastoma |
Baylor College of Medicine / Lingzhi Li, PhD |
Young Investigator Grants |
2024 |
Texas |
Capitalizing on functional genomics with targeted protein degradation in neuroblastoma |
St. Jude Children’s Research Hospital / Ian Delahunty, PhD |
Young Investigator Grants |
2024 |
Tennessee |
Translating sarcoma antigen-directed co-stimulatory NK cells to the clinic |
Baylor College of Medicine / Robin Parihar, MD/PhD |
Reach Grants |
2024 |
Texas |
Modifying CAR T cell epigenetic programs to improve therapy against aggressive pediatric brain tumors |
St. Jude Children’s Research Hospital / Meghan Ward, PhD |
Young Investigator Grants |
2024 |
Tennessee |
IGFBPL1 Peptide-Centric Chimeric Antigen Receptor Autologous T Cells for Relapsed HLA-A*02 Neuroblastoma and Medulloblastoma |
Children’s Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2024 |
Pennsylvania |
Exploiting a Novel DNA Repair Defect in Ewing Sarcoma |
Dana-Farber Cancer Institute / Shuhei Asada, MD/PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Uncovering new approaches to target FOXR2 in pediatric cancers |
Children’s Hospital Los Angeles / Jessica Tsai, MD/PhD |
'A' Award Grants |
2024 |
California |
Targeting Novel Inflammatory Signaling Pathways in Juvenile Myelomonocytic Leukemia |
Indiana University / Santhosh Kumar Pasupuleti, PhD |
'A' Award Grants |
2024 |
Indiana |
The influence of the raphe nucleus and serotonin on progression of diffuse intrinsic pontine glioma |
Stanford University / Richard Drexler, MD/PhD |
Young Investigator Grants |
2024 |
California |
Development of allogeneic off-the-shelf gamma delta T cell product for pediatric AML |
Baylor College of Medicine / Norihiro Watanabe, PhD |
Innovation Grants |
2024 |
Texas |